| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.035 | 0.9 |